MetCure provides its expertise in preclinical drug discovery and serves your need in target validation and lead identification.
We use pre-clinical models of human cancer to validate the in vitro and in vivo efficacy of your lead compounds
We perform molecular research to help you to identify mechanism of action (MOA) of your leads
- In vitro and in vivo toxicity
- Molecular docking